Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.932
Abstract: Heart failure oral therapies (HFOTs), including beta‐blockers (BB), renin–angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early… read more here.
Keywords: failure oral; heart; oral therapies; heart failure ... See more keywords
Impact of a fully integrated specialty pharmacy on patients’ out-of-pocket cost for oral therapies in a hematology clinic.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18928
Abstract: e18928Background: Oral therapies have revolutionized the treatment of cancer, providing alternatives to infusion therapies while increasing convenience and outcomes. However, patient financial burd... read more here.
Keywords: fully integrated; integrated specialty; hematology; specialty pharmacy ... See more keywords
Medication adherence among prostate cancer patients using advanced oral therapies.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.44
Abstract: 44Background: Prostate cancer (PC) is associated with a high clinical and economic burden. Advanced oral (AO) therapies have become the standard of care for patients with advanced PC, but real-worl... read more here.
Keywords: adherence among; medication adherence; prostate cancer; advanced oral ... See more keywords